Sandoz raises 2026 core EBITDA margin guidance to 23.0%-23.5%
Bitget2026/10/29 07:06- Sandoz narrowed its 2026 net sales growth forecast to 5-6% at constant currencies, from mid-to-high single-digit growth.
- Core EBITDA margin guidance rose to 23-23.5%, versus a previous forecast for roughly 100 basis points of year-over-year expansion.
- Short-term biosimilar supply constraints in Europe and International, alongside tougher German market conditions, weighed on sales expectations.
- Third-quarter sales rose 5% at constant currencies; biosimilar sales increased 17%, supporting a more favorable sales mix.
- The 2028 and 2030 outlooks remain unchanged, including a core EBITDA margin target of 25-27% by 2030.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Former Chainlink Product Marketing Director Michael Robinson joins Monad Foundation
The Federal Reserve Eyes $1.8 Trillion in “Shadow Credit”: Dallas and New York Fed Launch First Private Credit Survey
The Dallas and New York Federal Reserves have launched an investigation into private credit lending standards, covering an industry worth 1.8 trillions USD, with a minimum threshold of 50 millions USD. The results will be released in the first quarter of 2027.
Tom Lee Says a VIX Signal Points to a Stock Market Bottom
Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries
Morgan Stanley stated that the productivity dividends from AI are concentrated in 12 highly exposed industries, with growth rates reaching twice the twenty-year average. For the first time, signs of job replacement have emerged.
Crypto prices
More
